Q2 2019 Holdings
Filed 2019-08-14 | 219 holdings | $663.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $156.0M | 3,128,134 | 23.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $139.9M | 1,927,394 | 21.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $133.7M | 944,639 | 20.2% |
| Align Technology Inc(ALGN) | COM | 016255101 | $83.9M | 306,595 | 12.7% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $59.3M | 1,380,782 | 9.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $35.4M | 674,525 | 5.3% |
| Caredx Inc(CDNA) | COM | 14167L103 | $17.7M | 492,008 | 2.7% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $11.5M | 93,000 | 1.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $6.9M | 29,550 | 1.0% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $3.7M | 166,635 | 0.6% |
| Avantor Inc(AVTR) | COM | 05352A100 | $3.6M | 187,231 | 0.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $2.8M | 103,800 | 0.4% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $2.1M | 18,200 | 0.3% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $547.0K | 34,000 | 0.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $511.4K | 7,957,128 | 0.1% |
| Adobe Inc(ADBE) | COM | 00724F101 | $352.0K | 1,193 | 0.1% |
| Blackbaud Inc(BLKB) | COM | 09227Q100 | $343.0K | 4,107 | 0.1% |
| Incyte Corp(INCY) | COM | 45337C102 | $314.2K | 3,697,650 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $299.4K | 3,546,444 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $260.5K | 1,420,489 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $241.9K | 1,321,404 | 0.0% |
| Esperion Therapeutics Inc New(ESPR) | COM | 29664W105 | $188.8K | 4,057,411 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $175.7K | 1,341,428 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $171.0K | 1,850,000 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $166.6K | 6,840,785 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $141.7K | 8,247,860 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $101.8K | 360,739 | 0.0% |
| Teladoc Health Inc(TDOC) | COM | 87918A105 | $95.3K | 1,435,012 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $93.7K | 2,632,686 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $88.4K | 168,482 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $84.0K | 228,191 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $82.9K | 3,878,800 | 0.0% |
| Abbott Labs(ABT) | COM | 002824100 | $80.5K | 957,595 | 0.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $75.9K | 779,411 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $74.6K | 4,395,264 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $73.0K | 2,680,283 | 0.0% |
| Akcea Therapeutics Inc(AKCAEUR) | COM | 00972L107 | $72.7K | 3,100,768 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $72.2K | 1,069,200 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $69.2K | 4,724,246 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $64.0K | 241,212 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $63.4K | 1,264,913 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $56.6K | 711,803 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $51.9K | 1,369,604 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $50.1K | 350,698 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $48.5K | 4,118,806 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $47.4K | 194,394 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $47.4K | 332,173 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $39.5K | 1,515,002 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $39.3K | 3,650,000 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $38.8K | 855,609 | 0.0% |